Shandong Polymer Biochemicals Co Ltd

The company's capital structure is characterized by a low debt-to-equity ratio of 0.03, indicating a conservative leverage profile. Its liquidity position is reflected in a current ratio of 8.84, suggesting strong short-term liquidity. However, the price-to-earnings ratio of 8852.38 is extremely high, which may indicate a lack of earnings or a speculative valuation. The price-to-book ratio of 3.9 suggests that the market values the company at nearly four times its book value.

Profitability metrics are weak, with a return on equity (ROE) of 0.0004 and a return on assets (ROA) of 0.0004, both of which are near zero. The company reported a net income of 387,150 CNY despite a negative operating income of -111,270 CNY, indicating that non-operating items or one-time gains may have contributed to the bottom-line profit. Gross profit of 12,929,510 CNY represents a margin of approximately 16.64% of revenue, which is below the typical margins for the specialty chemicals industry.

The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segment and geographic diversification may expose the company to higher operational and market risks. The absence of detailed segment reporting limits the ability to assess the performance of different product lines or markets.

The company's growth trajectory is uncertain, as the available data does not provide forward-looking guidance or historical revenue growth rates. The operating cash flow of 36,639,610 CNY is positive, but the capital expenditure of -3,951,640 CNY suggests that the company is not investing heavily in expansion or modernization. The analyst estimate for the last actual EPS was 0.15 CNY, which is consistent with the low net income reported.

Risk factors include a medium liquidity risk, as the company has negative net cash after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. However, the company's high price-to-earnings ratio and low profitability metrics suggest that investors should closely monitor its earnings performance and operational efficiency.

Recent events include the disclosure of financial results, which show a net income despite a negative operating income. No recent filings or transcripts were provided in the available data, so there is no additional information on management commentary or strategic initiatives.

Shandong Newleaf Chemical (002476.SZ) has undergone a significant update to its corporate taxonomy, with its primary activity now formally classified as "Chemicals" and its economic sector identified as "Basic Materials." This structural clarification, marked as a medium-severity change, establishes a clearer framework for understanding the company's operational focus within the broader industrial landscape. Alongside these classification updates, the company’s risk profile has been refined with the introduction of specific risk assessments. The dilution risk is now categorized as "low," indicating a stable capital structure with minimal threat of share value erosion from new issuances. This assessment provides investors with greater confidence regarding the preservation of existing equity value. Conversely, the liquidity risk has been assessed as "medium," suggesting that while the company maintains operational stability, there may be moderate constraints or variability in its short-term cash flow management. This distinction is crucial for stakeholders evaluating the firm's ability to meet immediate financial obligations without undue stress. These changes collectively enhance the transparency of Shandong Newleaf Chemical’s financial and operational positioning. By defining its sectoral identity and quantifying key risks such as dilution and liquidity, the updated profile offers a more robust basis for investment analysis, even in the absence of current analyst coverage or index membership data.

The company generated CNY 31.9 million in free cash flow during the fourth fiscal year, demonstrating strong cash generation capabilities.

With a debt-to-equity ratio of 0.03, the firm maintains a highly conservative leverage profile compared to the cohort median of 0.23.

Revenue grew by 12.0% year-over-year to CNY 603.3 million in the latest fiscal year, indicating top-line expansion.

The company exhibits best-in-class cash conversion at 94.64%, significantly outperforming the cohort median of 1.08%.

Long-term debt decreased substantially from CNY 41.7 million in FY-1 to CNY 1.9 million in FY-4, reducing financial obligations.

Operating margin turned negative at -0.14%, placing the company in the bottom quartile of the specialty chemicals cohort.

Return on equity of 0.04% ranks in the bottom quartile, far below the cohort median of 3.93%.

The company faces high credit risk and medium liquidity risk, posing potential challenges for financial stability.